Role of biomarkers in monitoring exposures to chemicals: present position, future prospects
Authors:
- William P. WatsonWWWilliam P. Watson
- Antonio MuttiAMAntonio Mutti
- 1 January 2004
- journal article
- review article
- Published by Taylor & Francis in Biomarkers
- Vol. 9 (3) , 211-242
Abstract
Biomarkers are becoming increasingly important in toxicology and human health. Many research groups are carrying out studies to develop biomarkers of exposure to chemicals and apply these for human monitoring. There is considerable interest in the use and application of biomarkers to identify the nature and amounts of chemical exposures in occupational and environmental situations. Major research goals are to develop and validate biomarkers that reflect specific exposures and permit the prediction of the risk of disease in individuals and groups. One important objective is to prevent human cancer. This review presents a commentary and consensus views about the major developments on biomarkers for monitoring human exposure to chemicals. A particular emphasis is on monitoring exposures to carcinogens. Significant developments in the areas of new and existing biomarkers, analytical methodologies, validation studies and field trials together with auditing and quality assessment of data are discussed. New developments in the relatively young field of toxicogenomics possibly leading to the identification of individual susceptibility to both cancer and non-cancer endpoints are also considered. The construction and development of reliable databases that integrate information from genomic and proteomic research programmes should offer a promising future for the application of these technologies in the prediction of risks and prevention of diseases related to chemical exposures. Currently adducts of chemicals with macromolecules are important and useful biomarkers especially for certain individual chemicals where there are incidences of occupational exposure. For monitoring exposure to genotoxic compounds protein adducts, such as those formed with haemoglobin, are considered effective biomarkers for determining individual exposure doses of reactive chemicals. For other organic chemicals, the excreted urinary metabolites can also give a useful and complementary indication of exposure for acute exposures. These methods have revealed 'backgrounds' in people not knowingly exposed to chemicals and the sources and significance of these need to be determined, particularly in the context of their contribution to background health risks.Keywords
This publication has 66 references indexed in Scilit:
- Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-14C]-butadieneChemico-Biological Interactions, 2004
- Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-14C]-butadieneChemico-Biological Interactions, 2004
- Bias and confounding in molecular epidemiological studies: special considerationsCarcinogenesis, 1998
- Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic β-carbolinesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- COMMENTARY: Nature and nurture: possibilities for cancer controlCarcinogenesis, 1996
- Use of intermediate end-points to prevent long-term outcomesToxicology Letters, 1995
- On cancer risk estimation of urban air pollutionEnvironmental Health Perspectives, 1994
- Exposure of bus and taxi drivers to urban air pollutants as measured by DNA and protein adductsToxicology Letters, 1994
- Damage to DNA in cervical epithelium related to smoking tobacco.BMJ, 1993
- Correlation of DNA adduct levels in human lung with cigarette smokingNature, 1988